Price target
8.830.000.00%
The 6 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
SABS EPS for the last quarter is −0.21 USD despite the estimation of −0.23 USD. In the next quarter EPS is expected to reach −0.10 USD. Track more of SAB Biotherapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter SAB Biotherapeutics, Inc. revenue is expected to reach 0.00 USD. Check out SAB Biotherapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SABS price target is 8.83 USD with a max estimate of 14.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch SAB Biotherapeutics, Inc. stock price chart and keep track of the current situation with SABS news and stock market news.
We've gathered opinions of 6 analysts rating SABS stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.